Wealth Awesome
TSX closed
Loading markets…
PARTNER SPOTLIGHT
CIBC Investor's Edge

Buy the stocks you believe in, for less

For a limited time, trade fractional shares commission-free.¹

  • ✓Own a piece of your favourite companies without buying an entire share
  • ✓Stocks and ETFs, from as little as $1
  • ✓In any account: TFSA, FHSA, RRSP and more

¹Online fractional trades in North American equities under one share, Sep 15, 2026 to Oct 31, 2027. One qualifying order per security, per side, per day. Conditions apply.

Stocks/NASDAQ/MRNA

Moderna Inc (MRNA : NASDAQ)

$199.33USD+2.54 (1.29%)Close of 2026-11-19

Common Stock

Follow MRNA

MRNA

Moderna Inc

Source:WealthAwesomeWealthAwesome
↓ $25.67 (-11.41%)
30 day period
$196.79$232.89$269.00Oct 9Oct 30Nov 19

Performance

1 Day

+1.29%

1 Week

-13.84%

1 Month

-17.66%

YTD

+545.92%

The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.

Key Statistics

Market Cap

$90.38B

52W High

$280.80

52W Low

$22.28

P/E Ratio

-

50 Day MA

$201.67

200 Day MA

$96.41

Beta

1.17

Dividend Yield

-

Performance history

MRNA returns since 2018

Moderna Inc has returned −5.4% a year over the last 5 years, with 3 up years out of 7 full calendar years. Its deepest fall was −95.4% (Aug 2021 to Nov 2025).

1 year / yr

+724.4%

3 years / yr

+36.2%

5 years / yr

−5.4%

10 years / yr

—

Calendar-year returns

  • 2018*−17.9%
  • 2019+28.1%
  • 2020+434.1%
  • 2021+143.1%
  • 2022−29.3%
  • 2023−44.6%
  • 2024−58.2%
  • 2025−29.1%
  • 2026*+575.9%

* Partial year (first year of data, or year to date).

$10,000 invested in MRNA

  • 1 year ago$82,436
  • 5 years ago$7,557
  • 2018 (start of our data)$107,167
Best year
2020: +434.1%
Worst year
2024: −58.2%
All-time high in our data
$484 on Aug 9, 2021 · now −58.9%

Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Dec 2018 to Nov 2026. Past returns do not predict future ones.

Awesome Portfolio™

Looking past MRNA? Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/19/2026$196.03$205.22$189.98$199.33$199.338,204,149
11/18/2026$206.80$208.68$196.52$196.79$196.796,986,325
11/17/2026$219.85$222.43$203.84$206.80$206.808,277,036
11/16/2026$216.74$220.59$212.50$215.27$215.277,023,751
11/13/2026$224.90$231.35$221.70$223.37$223.378,048,600
11/12/2026$237.88$245.37$229.69$231.35$231.357,021,334
11/11/2026$252.78$254.86$243.00$248.69$248.697,589,229
11/10/2026$265.88$273.00$250.49$250.83$250.8311,149,939
11/9/2026$257.86$280.80$253.33$269.00$269.0012,357,425
11/6/2026$245.40$267.50$237.86$254.19$254.1916,296,200

Analyst Price Targets

Based on 23 analysts covering MRNA · as of Nov 17, 2026

📉

Wall Street analysts forecast MRNA stock price to fall 22.0% over the next 12 months.

Consensus

Hold

3.09 / 5.00

Avg. Target

US$155.50

-22.0% Upside

Previously US$154.47 on Nov 10, 2026

Current Price

US$199.33

Last close

Analyst Breakdown (23 analysts)

Strong Buy 3
Buy 1
Hold 16
Sell 1
Strong Sell 2
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MRNA's historical volatility

HistoricalForecast68%95%
US$52.24US$210.56US$368.88US$527.19US$685.51US$843.82TodayJul 16Sep 18Nov 19Jan 1Feb 14Mar 29

30-Day Vol

103.3%

Annualized

90-Day Vol

196.2%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

US$238.30

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$211.56US$148.12 – US$302.16
60 trading daysUS$224.53US$135.62 – US$371.72
90 trading daysUS$238.30US$128.52 – US$441.84

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Moderna Inc

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Financials

Revenue (TTM)
$2.52B
EBITDA
$-1.78B
Profit Margin
-110.46%
ROE (TTM)
-34.50%
EPS (Diluted)
-7.04
Book Value
16.92

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

Free newsletter

The Saturday TSX Wrap

Saturday morning

The week on the TSX, in five minutes

  • The biggest gainers and losers, and why they moved
  • Sector and momentum moves at a glance
  • The Canadian market stories you missed

Free. One email a week. Unsubscribe any time.

Common Questions About MRNA.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
SEATVivid Seats Inc$2.09+63.28%
MRKRMarker Therapeutics Inc$1.32+54.71%
ELOGEastern International Ltd.$1.45+46.46%
BAERBridger Aerospace Group Holdings, Inc. Common Stock$0.31+45.64%
ZKINZK International Group Co Ltd$1.65+32.00%
FLDFold Holdings, Inc. Class A Common Stock$0.29+27.19%
FISNDeep Fission, Inc. Common Stock$3.41+25.83%
ZEOZeo Energy Corp.$0.29+24.09%

Latest MRNA news

Wire stories from the last 10 days. Tap a headline for a preview.

  • Yahoo Finance · 3d ago

  • Yahoo Finance · 3d ago

Free with a Wealth Awesome account

Keep analysing MRNA, free

  • Every WA Score, ranking and table
  • Insider track records and SEDI filings
  • Earnings history and analyst targets for every stock

Email only, no password, no card. Already a member? Use the same button to sign in.